30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

STONE HEISZ LESLIE

Insider profile

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 78% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
STONE HEISZ LESLIE's trades of Edwards Lifesciences Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-12 2025-12-12 PrS Proposed sale
82,565
95.13
US$2,850,016
82,565 95.13 US$2,850,016
2025-12-12 2025-12-12 S Sale
35,176 -45.1%
392.29
US$2,315,273
35,176 -45.1% 392.29 US$2,315,273
2025-02-13 2025-02-13 PrS Proposed sale
28,386
213.48
US$645,379
28,386 213.48 US$645,379
2025-02-13 2025-02-13 S Sale
5,739 -16.0%
75.86
US$435,371
5,739 -16.0% 75.86 US$435,371
2024-07-11 2024-07-11 PrS Proposed sale
250
295.22
US$73,805
250 295.22 US$73,805
2024-07-02 2024-07-02 PrS Proposed sale
318
285.07
US$90,652
318 285.07 US$90,652
2024-02-08 2024-02-08 PrS Proposed sale
7,056
86.45
US$609,991
7,056 86.45 US$609,991
2024-02-08 2024-02-08 S Sale
7,056 -20.7%
86.45
US$609,991
7,056 -20.7% 86.45 US$609,991
2023-08-10 2023-08-10 PrS Proposed sale
3,303
78.87
US$260,508
3,303 78.87 US$260,508
2023-08-10 2023-08-10 S Sale
3,303 -10.9%
78.87
US$260,509
3,303 -10.9% 78.87 US$260,509
2023-02-16 2023-02-16 S Sale
9,671 -26.0%
76.82
US$742,942
9,671 -26.0% 76.82 US$742,942
2021-12-17 2021-12-15 S Sale
9,045 -79.3%
362.26
US$3,276,642
9,045 -79.3% 362.26 US$3,276,642
2021-04-23 2021-04-23 S Sale
6,707 -22.9%
97.52
US$654,067
6,707 -22.9% 97.52 US$654,067